市場調査レポート

合成生物学の世界市場

Synthetic Biology

発行 Global Industry Analysts, Inc. 商品コード 134341
出版日 ページ情報 英文 240 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
合成生物学の世界市場 Synthetic Biology
出版日: 2015年02月01日 ページ情報: 英文 240 Pages
概要

当レポートでは、合成生物学の世界市場に注目し、直接取材および二次情報調査から得られた市場データや分析情報から、2014-2020年の期間を対象に取引価額の実績と予測を、応用分野(エネルギー・化学、バイオテクノロジー・医薬品など)および地域(米国、カナダ、日本、欧州、アジア太平洋州、その他)別に提供するほか、過去6年にわたる市場の経緯や主要・精鋭参入企業51社の最新プロファイルなどをまとめて、お届けします。

第1章 イントロダクション、調査方法、製品の定義

  • 調査の信頼性とレポートの限界
  • 免責事項
  • データの解釈とレポート作成のレベル
    • 定量技法および分析法
  • 製品の定義と調査の範囲

第2章 エグゼクティブサマリー

  • 展望
    • 概略基礎知識
    • 合成生物学:現実化しつつある予言
    • 現況および将来分析
    • 分析:地域別
    • 分析:製品区分別
    • 分析:エンドユーザー市場別
    • 主な成長推進要因・主な懸念事項
    • 成長推進要因
    • 懸念事項
    • 将来の展望
  • 産業概要
    • 合成生物学 - プロモーションを必要とする新興領域
    • バイオテクノロジーに対する合成生物学の寄与
    • クレイグ・ヴェンターの人工生命体:合成生物学分野における偉業
    • Gen9のBioFab:合成生物学の画期的成果
    • 合成生物学分野における主な発展:概要
    • 競合情勢
    • 合成生物学市場における競合
  • 市場の動向、推進要因、および課題
    • 合成生物学は恩恵かあるいは破滅のもとか
    • 進歩が止まったようにも見える合成生物学
    • 弾みがつく合成生物学研究
    • 米国と欧州 - 加速する合成生物学分野の研究
    • 課題が山積する開発途上国での合成生物学
    • 合成生物学の進歩につながるシステム生物学
    • DNAシーケンシング技術が合成生物学の成長を加速
    • DNAシーケンシングコストの急落が市場成長を支える
    • システム生物学が合成生物学の進歩を導く
    • 合成生物学市場の発展を促す食品ほか基礎的ニーズの不足
    • 食品、水、エネルギー統計
    • 合成生物学は食品安全性の懸念を緩和するか?
    • GM作物 (遺伝子組み換え作物) の需要拡大が成長への道を開く
    • 合成生物学ベースの成分が勢いを増す、ほか
  • 合成生物学における主な研究結果
    • 生物学者は人工生命を生み出すため人工染色体を酵母へ移植
    • 合成遺伝子は創薬の新しい世界を開く
    • 研究者はペプトイドナノシートの製造を発表
    • ウィルス撃退における合成生物学
    • 人工食品における合成生物学
    • 藻類関連の問題に対処する合成生物学
    • 水質検査の可能性を持つ合成生物学、ほか
  • 合成生物学:概要
    • イントロダクション
    • 歴史背景
    • 合成生物学と遺伝子組み替え技術 - 比較
    • 各分野における合成生物学の範囲
    • 工学
    • 化学
    • 主要実現技術
    • シーケンシング
    • 製造
    • 試作
    • 計測
    • 市場:製品別
    • 中核製品/生物学的要素
    • 実現可能製品
    • 市場潜在性
    • 医薬品
    • 工業
    • 農業
    • 生命科学研究
    • 再生可能エネルギー
    • 潜在的用途
    • 低分子医薬の生体内合成
    • 生命化学の拡大
    • 化学工業の持続性
    • エネルギーおよび環境
    • バイオ材料およびスマート材料生産
    • 合成生物学の社会経済的関心およびリスク
    • 生物兵器の生産
    • 偶発的放出
    • ROI
    • 他分野との不協和
    • 漸進的進化
    • 半端な理解
    • 予期せぬ生態系への影響
    • 不測の遺伝子移動
    • 深刻化しつつある問題
    • 業界団体
    • Synthetic Biology Industry Association(SynBIA)
    • Industry Association of Synthetic Biology(IASB)
  • 製品開発/発売
  • 最近の産業動向
  • 主要企業
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • その他の国々
  • アジア太平洋
  • その他の地域

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MCP-6581

This report analyzes the worldwide markets for Synthetic Biology in US$ Thousands by the following Product Segments: Enabled Products, and Others. The report also analyzes the market by the following Application Areas: Energy and Chemicals, Biotechnology and Pharmaceuticals, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 51 companies including many key and niche players such as -

Amyris, Inc.
BP PLC
Chromatin Inc.
Evolva SA
Gevo, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. OUTLOOK

  • A Quick Primer
  • Synthetic Biology: Prediction Becoming Reality
  • Current and Future Analysis
  • Analysis by Region
  • Analysis by Product Segment
  • Analysis by End-Use Market
  • Key Growth Drivers and Major Concerns
  • Growth Drivers
  • Major Concerns
  • Future Outlook

2. INDUSTRY OVERVIEW

  • Synthetic Biology - An Emerging Discipline in Need of Promotion
  • Contribution of Synthetic Biology to Biotech
  • Craig Venter's Synthetic Life: Momentous Achievement in Synthetic Biology Field
    • Gibson Assembly®: Building Toolset for Synthetic Biology
  • Gen9's BioFab: Major Breakthrough in Synthetic Biology
  • Key Developments in the Synthetic Biology Field: A Synopsis
    • Synthetic Biology Products with Commercial Potential in the Future by End Market
  • Competitive Landscape
  • Competition in Synthetic Biology Market
    • Intrexon: Leader in Synthetic Biology Field
    • Key Factors Contributing to Intrexon's Success in Synthetic Biology Field
      • Proprietary Suite of Innovative Technologies
      • Unique ECC-based Business Model
      • A Synopsis of Intrexon's ECC Agreements: 2011-2013

3. MARKET TRENDS, DRIVERS, AND ISSUES

  • Is Synthetic Biology a Bane or Boon?
  • Synthetic Biology Exhibits Plateau in Awareness
  • Synthetic Biology Research Gathers Momentum
  • US and Europe - Propelling Research in the Field of Synthetic Biology
    • Table 1: Number of Entities Focused on Synthetic Biology Research Globally: 2009 & 2013 (includes corresponding Graph/Chart)
    • Table 2: Synthetic Biology and their Potential Areas of Applications Being Researched by Biological Systems Manufacturers/Designers (includes corresponding Graph/Chart)
    • Table 3: Number of Biological Systems Manufacturers/Designers Focused on Specialty/Fine Chemical Applications (includes corresponding Graph/Chart)
    • Table 4: Number of Patent Filings Related to Synthetic Biology: 2003-2013 (includes corresponding Graph/Chart)
    • Table 5: Leading Filers of Patent Applications Related to Synthetic Biology: 2003-2013 (includes corresponding Graph/Chart)
  • Synthetic Biology Mired by Challenges in Developing Countries
  • Synthetic Biology Bringing a Paradigm Shift in the Field of Biological Research
  • DNA Sequencing Technique Propelling Growth for Synthetic Biology
  • Plummeting Cost of DNA Sequencing Bolsters Market Growth
    • Table 6: Cost per Genome Sequencing: 2001-2014
  • Systems Biology Leading to Advancements in Synthetic Biology
  • Synthetic Biology based Microbial Factories for Production of Poppies
  • Food and Other Basic Needs' Scarcity to Fuel Synthetic Biology Market
  • Food, Water, and Energy Statistics
    • Table 7: Top 20 Countries Worldwide in Terms of Population in Million (2014) (includes corresponding Graph/Chart)
  • Will Synthetic Biology Mitigate Food Security Concerns?
  • Growing Demand for GM Crops Opens Up Growth Avenues
  • Synthetic Biology-based Ingredients Gain Traction
  • Role of Synthetic Biology in Producing Plants with Desirable Characteristics
  • Do-It-Yourself Biology (DIYBio): A Growing Phenomenon
  • Synthetic Biology Ingredients in Consumer Products - Laden with Concerns
  • Synthetic Biology Gaining Prominence in Biomedical Applications
  • Research Efforts in Full Swing to Treat Life-Threatening Diseases using Synthetic Biology
  • Synthetic Biology Therapeutics to Address Antibiotic-Resistance Crisis
  • Pipeline Perspective of Synthetic Biology Therapeutics (Synthetic Biologics and Intrexon Collaboration)
  • Synthetic Biology for Wildlife Conservation Laden with Risks
  • Synthetic Biology Enabling Creation of Advanced Biosensing Systems
  • Synthetic Biology Gains Significance in Production of Bio-Based Chemicals and Biofuels
  • Contribution of Synthetic Biology to Renewable Chemicals
  • Synthetic Biology for Energy Supply: Potential Threat to Biodiversity
  • SynBio Products and Ingredients Face Opposition from Several Organizations
  • Lack of Regulatory Framework - A Major Concern

4. KEY RESEARCH FINDINGS ON SYNTHETIC BIOLOGY

  • Biologists Implants Artificial Chromosome in Yeast to Create Artificial Life
  • Synthetic Genes to Open New World of Drug Development
  • Researchers Announce Production of Peptoid Nanosheets
  • Synthetic Biology in Repelling Viruses
  • Synthetic Biology in Engineered Food
  • Synthetic Biology to Address Issues Related to Algal Blooms
  • Synthetic Biology Holds Potential for Testing Water Purity
  • Mars - A Home Away from Home Courtesy Synthetic Biology
  • Predictable Biological Systems - No More a Myth
  • Researchers at JCVI Make Novel Advances in Synthetic Genomics
  • Synthetic Biology Tools Can Detect Listeria Contamination in Food Products
  • Synthetic Biology Accelerates Flu Vaccine Production
  • Bioengineers at Duke University Develops Novel System for Reproducing Natural Complex Gene Regulation
  • TALE: A Viable Technology for Synthetic Protein Development
  • Can Synthetic Biology Fuel Cars or Household Power Supplies Using Naturally-Existing Fatty Acids?
  • Researchers Engineered Synthetic Compound to Defend Iron Deficiency
  • Cellular Circuit Designing Made Possible through Biological Genes
  • Meshing Inputs/Outputs Offer Layered Circuits
  • Cambrian Genomics Pioneers DNA Laser Printer
  • Researchers Develop Novel Technique that Speeds the Process for Developing New Biological Parts
  • Researchers Develop Novel Biological Device that Mimics Transistor-Like Properties

5. SYNTHETIC BIOLOGY - AN OVERVIEW

  • Introduction
  • Historical Background
  • Synthetic Biology Vis-a-vis Genetic Engineering - A Comparison
  • Scope of Synthetic Biology in Various Fields
  • Engineering
  • Chemistry
  • Major Enabling Technologies
  • Sequencing
  • Fabrication
  • Modeling
  • Measurement
  • Synthetic Biology Market - By Product
  • Core Products/Biologic Components
    • Synthetic Genes
    • Synthetic Cells
    • Chassis Organisms
      • Escherichia coli
      • Bacillus subtilis
      • Yeast
      • Mycoplasma
      • Acinetobacter
      • Mycoplasma genitalium
    • XNA (Xeno Nucleic Acid)
  • Enabling Products
    • DNA Synthesis
    • Oligonucleotide Synthesis
  • Market Potential
  • Pharmaceutical
  • Industrial
  • Agriculture
  • Life Sciences Research
  • Renewable Energy
    • Synthetic Biology Applications/Products with Highest Potential for Commercialization by 2030
  • Potential Uses
  • Biomedicine
    • Intricate Molecular Devices Utilized for Tissue Regeneration/Repair
    • Smart Drugs
    • Biological Delivery Systems
    • Vectors for Therapy
    • Personalized Medicine
    • Cells with Novel Properties for Betterment of Human Health
  • In Vivo Synthesis of Small-Molecule Pharmaceuticals
    • Intricate Natural Products
  • Expansion of Chemistry of Life
    • Expanding Genetic Alphabet
    • Nucleic Acids
    • Proteins
    • New Imaging and Targeting Methods
  • Chemical Industry Sustainability
    • Eco-friendly Production of Chemicals
  • Energy and Environment
    • Bioremediation
    • Energy Production
  • Biomaterials and Smart Materials Production
    • Synthesis
    • Organization
  • Socio-Economic Concerns and Risks of Synthetic Biology
  • Production of Bio-Weapons
  • Accidental Release
  • Return on Investment
  • Dissonance with Other Disciplines
  • Continuous Evolution
  • Curtailed Understanding
  • Unpredictable Ecosystem Effects
  • Unexpected Transfer of Genes
  • Aggravating Problems
  • Industry Associations
  • Synthetic Biology Industry Association (SynBIA)
  • Industry Association of Synthetic Biology (IASB)

6. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Synthetic Biologics Obtains Orphan Drug Designation for SYN-005 mAb
  • Agilent Technologies Introduces SureGuide Kits
  • Agilent Technologies Rolls Out ClearSeq AML Next-Generation Sequencing Cancer Research Panels
  • Gen9 Rolls Out Variant Libraries
  • Gen9 Introduces GeneByte Plus™ DNA Constructs
  • Agilent Technologies Introduces SureSelect Clinical Research Exome
  • Agilent Technologies Launches QuikChange HT Protein Engineering Synthetic Biology System
  • GenScript Introduces GenEZ™ Next-Generation Molecular Cloning Service
  • DNA2.0 Releases CRISPR/Cas9 Tools for Genome Editing and Engineering
  • GenScript Unveils GenPlus™ Next-Generation Gene Synthesis Technology
  • Life Technologies Introduces new GeneArt® Algae Protein Expression Kits
  • Life Technologies Unveils Vector NTI® Express Designer Bioinformatics Software Platform
  • Gen9 Introduces GeneBytes™ DNA Constructs
  • New England Biolabs and Synthetic Genomics Launches Gibson Assembly Cloning Kit and NEBuilder™ Primer Design Tool
  • GenScript Introduces Gene-Brick™ Gene Synthesis Service

7. RECENT INDUSTRY ACTIVITY

  • Genome Compiler Enters into Collaborative Agreement with DNA2.0
  • Eurofins Genomics Enters into Co-operation Agreement with Igenbio
  • Bacterial Robotics Signs Strategic Agreement with Bacmine
  • Intrexon and Histogenics Enter into Exclusive Channel Collaboration for Cartilage Repair Therapies
  • Intrexon and Amneal Pharmaceuticals Announce Second Exclusive Channel Collaboration for a Target API
  • Synthetic Biologics and FUJIFILM Diosynth Biotechnologies Announces Positive Phase I Outcomes of API Manufacturing of SYN-004
  • Evolva Holding Acquires Prosarix
  • Igenbio Collaborates with Genome Compiler
  • Pareto Biotechnologies Enters into Technology Partnership with DNA2.0
  • Roche Enters into Research Agreement with Stratos Genomics
  • Cellectis Enters into Agreement with Thermo Fisher Scientific
  • Roche Acquires Genia Technologies
  • Synthorx, a New Synthetic Biotechnology Company Launches
  • Synthetic Genomics Enters into Long-Term R&D Agreement with Lung Biotechnology
  • OriGene Introduces Genome-wide Gene-knockout Kits
  • Intrexon Concludes Acquisition of Medistem
  • Amyris Enters into Collaborative R&D Agreement with BASF
  • MIT SBC Collaborates with Pfizer
  • Tauriga Sciences Acquires Pilus Energy LLC
  • OvaScience and Intrexon Enter into Agreement
  • Sanofi Commences Large-Scale Production of Semi-Synthetic Artemisinin
  • EVOLVA and IFF Enter into Pre-Manufacturing Phase for Natural Vanillin
  • Synthetic Genomics Enters into Research Agreement with ExxonMobil
  • Amyris Signs Long Term Agreement with International Flavors & Fragrances
  • SGI-DNA and IDT Announce Expanded Collaboration
  • College of Engineering Establishes BU Center of Synthetic Biology
  • Gen9 Enters into Partnership with Agilent Technologies
  • AquaBounty Technologies Enters into Exclusive Channel Collaboration with Intrexon
  • Synthetic Biologics Collaborates with Intrexon for Infectious Disease Therapies
  • DuPont Collaborates with OligoCo
  • DNA2.0 Collaborates with Newcastle University
  • Amyris Secures Contract from the US DARPA
  • Pfenex Collaborates with DNA2.0
  • Synthetic Genomics Inks Agreement with New England Biolabs
  • Amyris Commences Production of Biofene in Brazil

8. FOCUS ON SELECT PLAYERS

  • Players Focused on Synthetic Biology Applications
  • Amyris, Inc. (US)
  • BP PLC. (UK)
  • Chromatin Inc. (US)
  • Evolva SA (Switzerland)
  • Gevo, Inc. (US)
  • Joule Unlimited, Inc. (US)
  • Metabolix (US)
  • MorphoSys AG (Germany)
  • Sapphire Energy, Inc. (US)
  • Solazyme, Inc. (US)
  • Synthetic Biologics, Inc. (US)
  • Synthetic Genomics, Inc. (US)
  • Players Focused on Gene Synthesis and Tools
  • 454 Life Sciences (US)
  • Agilent Technologies Inc. (US)
  • ATG Biosynthetics GmbH (Germany)
  • DNA2.0 (US)
  • Epoch Life Science, Inc. (US)
  • Gen9, Inc. (US)
  • GenScript USA, Inc. (US)
  • Gingko Bioworks, Inc. (US)
  • Intrexon Corporation (US)
  • LC Sciences LLC (US)
  • Life Technologies Corp. (US)
  • OPXBIO, Inc. (US)
  • OriGene Technologies, Inc. (US)
  • Sangamo BioSciences, Inc. (US)
  • Verdezyne, Inc. (US)

9. GLOBAL MARKET PERSPECTIVE

    • Table 8: World Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 9: World Historic Review for Synthetic Biology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 10: World 14-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 11: World Recent Past, Current & Future Analysis for Synthetic Biology by Product Segment - Enabled Products and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 12: World Historic Review for Synthetic Biology by Product Segment - Enabled Products and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 13: World 14-Year Perspective for Synthetic Biology by Product Segment - Percentage Breakdown of Dollar Sales for Enabled Products and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 14: World Recent Past, Current & Future Analysis for Synthetic Biology by End-Use Sector - Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 15: World Historic Review for Synthetic Biology by End-Use Sector - Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 16: World 14-Year Perspective for Synthetic Biology by End-Use Sector - Percentage Breakdown of Dollar Sales for Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • Research in the US
    • Table 17: Number of Entities Focused on Synthetic Biology Research in the US (2009 & 2013) (includes corresponding Graph/Chart)
    • International Genetically Engineered Machine (IGEM) - A Platform for Innovations
    • Product Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 18: US Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 19: US Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

2. CANADA

  • Market Analysis
    • Table 20: Canadian Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 21: Canadian Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

3. JAPAN

  • Market Analysis
    • Table 22: Japanese Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 23: Japanese Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Research in Europe
    • Table 24: Number of Entities Focused on Synthetic Biology Research in Europe (2009 & 2013) (includes corresponding Graph/Chart)
    • Table 25: Number of Entities Focused on Synthetic Biology Research by Area of Interest: 2013 (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 26: European Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 27: European Historic Review for Synthetic Biology by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 28: European 14-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 29: French Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 30: French Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Key Players
  • B. Market Analytics
    • Table 31: German Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 32: German Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 33: Italian Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 34: Italian Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Market Overview
    • UK Government Awards Over £6 Million Grant for Synthetic Biology
      • UK Government Funding for Synthetic Biology: 2013
    • Synbicite Centre to Spearhead UK Research In Synthetic Biology
    • UK Sets Up New Synthetic Biology Research Centers
      • Synthetic Biology Research Centre Nottingham (Sbrc Nottingham)
      • Bristol Centre for Synthetic Biology (Brissynbio)
      • Openplant Synthetic Biology Research Centre
    • University of Edinburgh inks Agreement with Bgi to Develop Artificial Yeast Genome
    • Strategic Corporate Development
    • BP Plc. - A Key Player
  • B. Market Analytics
    • Table 35: UK Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 36: UK Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 37: Spanish Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 38: Spanish Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

4f. REST OF EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Evolva SA (Switzerland) - A Major Player
  • B. Market Analytics
    • Table 39: Rest of Europe Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 40: Rest of Europe Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Table 41: Number of Entities Focused on Synthetic Biology Research in Asia and Oceania in 2013 (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 42: Asia-Pacific Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 43: Asia-Pacific Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 44: Rest of World Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 45: Rest of World Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top